The invention and patenting of the Medanta Anterior Oblique Lateral Oblique (MAOLO) template represents a substantial advancement in the treatment of late-stage cervical cancer, according to Medanta Hospital in Gurugram. This new device is a breakthrough in the field of image-guided adaptive brachytherapy for larger pelvic tumors. It was conceived by Associate Director Susovan Banerjee and developed in collaboration with the Medanta Medical Physics Team and Tejinder Kataria, Chairperson of the Division of Radiation Oncology, Cancer Institute.
When it comes to treating large cervical tumors, particularly those that are larger than 100 cm, the MAOLO template fills a crucial need. Up until now, only 36cc tumors could be managed with commercially available applicators. With bigger tumors frequently present, individuals with advanced-stage cervical cancer have few viable treatment options due to this constraint. This need is filled by the MAOLO template, which offers a high-precision, user-friendly solution that improves these patients’ response to radiation therapy.
The MAOLO template was carefully and rigorously developed and approved. It satisfies the highest standards of safety and efficacy because it has been approved by the Independent Ethics Committee and Medanta Institutional Review Board. The intended use for the device is image-guided adaptive brachytherapy, which is a procedure in which the radiation source is positioned in close proximity to the tumor. This method lessens negative effects by delivering a higher radiation dose to the tumor while protecting nearby healthy tissue.
The patient-friendly design of the MAOLO template is one of its main benefits. Conventional commercial brachytherapy applicators can be large and painful, requiring a lot of anesthesia and painkillers and frequently needing extended hospital stays. On the other hand, the MAOLO template is made to be comfortable and simple to use. It makes the process easier, requiring less strong anesthetic and painkillers, and it permits shorter hospital stays, which enhances the patient experience overall.
A major contributor to the MAOLO template’s development, Tejinder Kataria, emphasized how well it worked to get around the drawbacks of the applicators that were already in place. In addition to making patients feel more at ease, the MAOLO template makes the assembly process easier for medical professionals. This ease of use results in more effective and efficient treatments, lessening the workload for medical personnel as well as patients.
The significance of this finding was underscored by Medanta’s Chairman and Managing Director, Naresh Trehan, within the wider framework of cervical cancer care in India. He said that Medanta’s dedication to creating top-notch medical innovations that enhance patient outcomes is best demonstrated by the MAOLO template. This invention offers a new tool that can meet the demands of patients who previously had few options, which is a significant advancement in the treatment of cervical cancer. Trehan’s remarks highlight Medanta’s commitment to quality and innovation in healthcare, guaranteeing that they will keep offering state-of-the-art solutions to their local community.
A ground-breaking development in the management of advanced cervical cancer is the MAOLO template. By providing a more accurate and user-friendly substitute for conventional commercial applicators, it can greatly enhance both treatment effectiveness and patient comfort. This breakthrough is a major turning point in the treatment of cervical cancer and demonstrates Medanta’s dedication to enhancing patient outcomes using cutting-edge medical technology.
SOURCE:
BW HEALTHCARE WORLD
